OBJECTIVE -To determine the prevalence of depression in adult diabetic populations through a comprehensive literature review and to critically evaluate the methods and findings of such studies from an epidemiological perspective.
T he comorbidity of mental and physical illness is currently of considerable interest. It is generally accepted that an increased risk of psychiatric disorder accompanies the presence of a medical illness (1) (2) (3) (4) . Recent studies have indicated that depression may be especially prevalent in people with diabetes (5) (6) (7) (8) . Recognition and treatment of depression in diabetic individuals is important for alleviation of the psychiatric condition. Recognition and treatment of depression may also be important for diabetes itself, as depression has been associated with both poorer glucose regulation (9) (10) (11) (12) and decreased adherence to the treatment regimen (13, 14) .
In 1983 we reviewed the available evidence regarding the association of depression and diabetes. At that point, we concluded that "the incidence and prevalence of depression in diabetic populations was unknown" (15) . The past decade of research has seen substantial investigative scrutiny regarding the prevalence of depression in individuals with the disease. These studies have used various treatment and community samples, depression assessment modalities, and study designs. The dual purpose of this review was to ascertain the prevalence of depression in diabetes in light of recent investigations, and to critically evaluate these studies from an epidemiological perspective in terms of methods and findings.
RESEARCH DESIGN AND METHODS

Selection of articles
A computer-generated literature review of all available existing studies on the prevalence of depression in diabetic populations was undertaken. Additional studies were gleaned from examining the reference lists of papers that were obtained, or from studies that had been presented in part as abstracts or symposia at national meetings. No time constraints were imposed on when the pa-DIABETES CARE, VOLUME 16, NUMBER 8, AUGUST 1993 pers had to have been published or presented. All articles had to have been published in English.
Studies were limited to adult samples (> 18 yr of age) to facilitate comparison of the psychiatric methodologies used. Individual case reports were not considered, although no other sample size restrictions were imposed. Articles were evaluated only if they involved persons who had been diagnosed with IDDM or NIDDM. Designations such as impaired glucose tolerance, borderline diabetes, or gestational diabetes were not considered. The search yielded no studies involving psychiatric assessments of people with malnutrition-related diabetes or maturity-onset diabetes in the young. Review articles were not considered, and papers that had been published over time on the same series of subjects were considered as one study.
Papers were divided into controlled and uncontrolled studies for the purposes of evaluation. A study was considered controlled if it involved a comparison group in addition to the diabetic group and if both groups were assessed with the same structured diagnostic interview or depression symptom scale. Studies that involved a psychiatric evaluation of a diabetic group and then cited references of control groups for comparison purposes were considered uncontrolled studies. Controlled and uncontrolled studies were further subclassified according to structured diagnostic interviews or depression symptom scales to facilitate tabulation and evaluation.
Data analysis
A traditional meta-analysis of the collection of articles was not performed because of the great variability in depression assessment methods. The definition of depression caseness could have been achieved through any of several structured diagnostic interviews for major depressive disorder. Numerous corroborating depression symptom scales with varying cutoffs designating clinically significant depression symptomatology were also used. Studies that contained similar assessment methods were very few in number, and even if such studies had been combined, the categories still would have been too small for effective analysis. Variability in the characteristics and source of the samples further prohibited effective meta-analysis. Each study was therefore examined individually, and the findings were tabulated.
The prevalence of depression was determined for both a diabetic group and its control group by the diagnostic criteria of the structured interview. Current and lifetime prevalences of depression were included where appropriate. The proportion above a cutoff score designating clinically significant depression symptomatology on a self-report scale was determined for a diabetic group and its comparison group to corroborate the findings of the interview studies. If studies using depression symptom scales did not contain such information, but provided the sample size, mean, and SD of the depression scores, the sample proportion above the cutoff was calculated. X 2 tests with Yates' correction for continuity were used to determine if a diabetic group differed significantly from its control group in the prevalence of depression or clinically significant depression symptomatology. Sex-specific differences were also assessed in this manner. Sex differences were measured within a particular diabetic or control group. Differences in mean depression symptom scores were calculated using Student's t test. (20) . The use of spouses may underestimate differences in depression caused by assortative mating and the fact that spouses living with a depressed person frequently become depressed themselves (21) (22) (23) .
Critical review
Individuals with diabetes may be compared with either individuals with a different somatic illness or with healthy control subjects. It is essential in either comparison, however, that an increased prevalence of depression be attributable to diabetes rather than to concomitant diseases in the diabetic sample. Similarly, the other somatic illness group should not have additional diseases present that could minimize true differences in depression. Biased estimates may also occur if the diabetes and other somatic illness groups differed from each other in terms of severity. If severity of diabetes and/or depression were the impetus behind diabetic patients seeking medical care, the use of treatment samples from a single hospital or clinic could further result in an ascertainment bias that could artificially inflate the depression prevalence estimates in the diabetes group.
Methodological issues, such as verification of a diagnosis of diabetes, the time frame of depression being mea- *DIS for diagnosis of major depressive disorder by lay interviewers, based on criteria specified in the DSM-III. tCIS for diagnosis of major depressive disorder by psychiatrists and psychologists. fPSE, which assesses the present mental state. An Index of Definition Score >5 designates a psychiatric case; a diagnosis of depression is subsequently based on equivalent ICD-9 criteria.
§Beck Depression Inventory Scale. ||Zung Self-Rating Depression Scale. #Center for Epidemiologic Studies-Depression Scale. sured, the sample size, and participation rate, were also examined.
RESULTS-
The search yielded 9 controlled studies (5-9,20,24- Table  3 ). Because control groups are essential and basic to epidemiological research, the following discussion will emphasize the controlled studies.
Controlled studies
The 9 controlled studies contained 4 structured diagnostic interview studies (5, 6, 20, 24 ) and 5 depression symptom scale studies (7) (8) (9) 25 Table 1 ). The 4 interview studies involved two community samples and two treatment samples. Two types of control groups were represented, which reflected the focus of the research question being addressed: 1) individuals free of diabetes or any other disease; or 2) nondiabetic individuals having a different chronic illness. The former asks if diabetes is associated with an increased risk of depression. The latter asks if diabetes can be distinguished from other chronic illnesses in the risk of depression. The second question is particularly crucial in that most somatic illnesses are associated with an increased prevalence of depression, and there may be nothing about diabetes that differentiates it from this general rule (4, 36) . The variety of diabetic and control sample sources is given in Table 1 . Structured diagnostic interviews. Three structured diagnostic interview methodologies were used to assess the prevalence of major depressive disorder in the 4 controlled interview studies (Table 1). These included the National Institute of Mental Health DIS, the PSE, and the CIS.
The DIS was used in 2 controlled interview studies (6, 24) . The DIS has been shown to be a reliable and valid instrument for making psychiatric diagnoses in accordance with criteria specified in the DSM-III of the American Psychiatric Association (37, 38) . Lifetime and current psychiatric histories are assessed by lay interviewers. In addition to DIABETES CARE, VOLUME 16, NUMBER 8, AUGUST 1993 the categorization of a psychiatric disorder as present or absent, the DIS obtains information on the frequency, duration, and severity of psychiatric episodes. Originally developed for the Epidemiologic Catchment Area Program, a multisite investigation to determine the prevalence of psychiatric diagnoses in the general population of the U.S. (39) , the DIS has also been found to be suitable for use in diabetic treatment samples (12, 40) .
The PSE was used in 1 controlled interview study (20) . This instrument was originally developed for hospital inpatients, and thus has strict inclusion criteria for a diagnosis of major depressive disorder (41) . Subjective evaluation by clinicians determines whether symptoms are absent, present in a moderate degree, or present in a severe degree. These ratings are then compiled to classify patients by specific psychiatric diagnoses. The PSE has been adapted for use in community settings (42). Relatively low indexes of agreement for test-retest ratings may be indicative of the rapid fluctuation in symptomatology in the assessment period of 1 mo before the interview (43,44). Few systematic attempts to validate the PSE with other diagnostic interview procedures have been performed. Poor agreement on individual symptoms but high agreement on syndrome classification and diagnostic class were found in 1 study (45).
Major depressive disorder was diagnosed with the CIS in the remaining controlled interview study (5) . The CIS was developed for use in community settings and is administered by psychiatrists and psychologists (46). Symptomatology is assessed for the week before interview and rated on a 5-point scale from 0 (absent) to 4 (severe). Observed abnormalities of the subject during the interview itself are also recorded. The rated symptoms and manifest abnormalities are tabulated and psychiatric diagnoses are made according to International Classification of Disease criteria. Although the interviewer is allowed considerable freedom in subjectively assessing symptoms and abnormalities, inter-rater reliability of the CIS has been found to be high (0.92) (46). Depression prevalence estimates. Diabetes versus nondiabetes-Three of four diabetic samples from structured diagnostic interview studies had a significantly increased prevalence of major depressive disorder than their respective nondiabetic control group (Table 2) . Differences were found in current (5,6) as well as lifetime depression (6, 24) . The range of the prevalence of current depression in the diabetic samples was 8.5-27.3% (X = 14.0% when studies were weighted equally). When depressed diabetic cases were summed across studies and divided by the total number of diabetic subjects, the prevalence of current depression was 11.8%. Studies with larger samples are weighted heavier in the latter. The 5 investigations using depression symptom scales corroborated these findings, as all five diabetic samples had a significantly higher prevalence of clinically significant depression symptomatology or a significantly higher mean level of depression symptoms than their respective nondiabetic control group ( Table 2 ). The range of clinically significant depression symptomatology in the diabetic samples was 21.8-60.0% (X = 32.4%). The prevalence of current depression was identical for diabetic cases and nondiabetic control subjects in 1 interview study (20) . Sex-specific and intragroup estimatesSex-specific prevalence estimates of major depressive disorder were provided in only 1 diagnostic interview controlled study (Table 2) . Male IDDM pancreatic transplant candidates had a significantly greater prevalence of lifetime depression than males from the general population (25.9 vs. 3.1%; P < 0.001) (6) . Significant differences were found for the corresponding female groups in lifetime (22.9 vs. 7.1%; P < 0.001) as well as current depression (14.6 vs. 4.0%; P < 0.001). The latter results were corroborated by 1 depression symptom scale study in that diabetic females had a significantly greater prevalence of clinically significant depression symptomatology than nondiabetic females (25.4 vs. 17.6%; P < 0.05) (8) . Intragroup comparisons showed that diabetic females had a higher rate of current depression than diabetic males (14.6 vs. 3.7%) (6) . Corroboration was provided by the depression symptom scale study, which found that diabetic females had a greater prevalence of clinically significant depression symptomatology than diabetic males (25.4 vs. 15.5%). Neither comparison was significant, however, because of the low number of diabetic males who were depressed (1) or whose depression symptoms achieved clinical significance (9) .
Uncontrolled studies
The 11 uncontrolled studies contained 5 structured diagnostic interview studies (10, (27) (28) (29) Table 3 ). All involved treatment samples except for 1 interview study, which contained a community sample (A. Biglan, D. Toobert, R. Farmer, W. Wilson, D. Campbell, unpublished observations). The community sample, however, was not a systematic sampling of a given location, but consisted of volunteers. The various sample sources are given in Table 3 . Structured diagnostic interviews. Five structured diagnostic interview methodologies were used to assess the prevalence of major depressive disorder in the 5 uncontrolled interview studies ( Table  3 ). The DIS, PSE, and CIS have been described previously. Other procedures included the SADS and the IDD-L.
The SADS was used in 1 uncontrolled interview study (A. Biglan, D. Toobert, R. Farmer, W. Wilson, D. Campbell, unpublished observations). This instrument was designed for use with Prevalence findings reflect those of major depressive disorder for structured diagnostic interviews and clinically significant depression symptomatology for depression symptom scales. ""Prevalences reflect those of any affective disorder, which include major depression, dysthymia, and mania. Mania represented only 2.9% of all affective disorders in this study sample. tThe actual prevalence of clinically significant depression symptomatology among the diabetic and control groups in this study was unknown. =fNS compared with respective overall or sex-specific diabetic group in prevalence of depression or mean depression scale scores. §P < 0.05 compared with respective overall or sex-specific diabetic group in prevalence of depression or mean depression scale scores. \\P < 0.01 compared with respective overall or sex-specific diabetic group in prevalence of depression or mean depression scale scores. HP < 0.001 compared with respective overall or sex-specific diabetic group in prevalence of depression or mean depression scale scores. psychiatric patients and is administered by clinicians (47). It has also been used to measure major depressive disorder in community samples (48). Current symptoms are assessed for the week before interview and are rated on a 6-point scale from 1 (absent) to 6 (extreme). Symptoms are also measured when the current episode is most severe. Lifetime disorders prior to the year before interview may also be assessed. Ratings are used to make psychiatric diagnoses in accordance with the Research Diagnostic Criteria (49), an earlier nomenclature of criteria to DSM-III. Inter-rater reliability with the SADS has been found to be excellent for most disorders (49).
The IDD-L was used in the remaining uncontrolled interview study (27) . Strictly speaking, this instrument is not an interview methodology, but a 22-item self-report questionnaire (50). Depression symptoms are rated on a 5-point scale of increasing severity. The IDD-L is nevertheless diagnostic for lifetime major depressive disorder according to DSM-III criteria. Validation studies have documented good concordance between the IDD-L and the DIS for lifetime depression (50). tIDD-L Scale. This self-report instrument assesses lifetime prevalence of major depressive disorder based on criteria specified in the DSM-III. =fPSE, which assesses the present mental state. An Index of Definition Score >5 designates a psychiatric case; a diagnosis of depression is subsequently based on equivalent ICD-9 criteria.
§ General health questionnaire. ||CIS for diagnosis of major depressive disorder by psychiatrists and psychologists. HDIS for diagnosis of major depressive disorder by lay interviewers, based on criteria specified in the DSM-III. Table 3 ). The current depression compared with diadepressive disorder (10, 27) , and 4 mea-range of current depression was 11.0-betic males in all 4 studies, although sured current major depressive disorder 22.2% (X = 15.4% with equal or un-differences were significant in only 1 (+), Potential bias adjusted for in either sample selection or analyses, or no significant differences found between diabetic and control groups; (-), potential bias not adjusted for in either sample selection or analyses; (n/a), bias not applicable to study. *Severity was defined according to the focus of the study. The diabetes and other somatic illness comparison groups did not differ significantly in severity of medical illness (5); diabetes severity was unrelated to depression, which minimizes an ascertainment bias from the use of treatment samples (6, 20) . tThe 25-to 44-yr category contained 76% of the IDDM pancreatic recipients, 62% of the family donors, and 39% of the general population (P < 0.001). fThe mean age was 51 ± 6.6 yr in the diabetic sample and 44 ± 10.4 yr in the control sample (P < 0.01). §The proportion of low socioeconomic status occupations represented in the diabetic and control samples was 63 and 45%, respectively (P < 0.01). |)The proportion unemployed was 75% in the diabetic sample and 37% in the control sample (P < 0.01). study (10) . The range of clinically significant depression symptomatology in the 6 depression symptom scale studies was 10.0-28.0% (X = 19.6%).
Critical review
Methodological problems and adjustments for potential biases are summarized for the 4 diagnostic interview controlled studies and the 5 corroborating depression symptom scale controlled studies in Table 4 . Although all studies accounted for some factors through either sample selection or analyses, many potential biases were not addressed. Age. All 4 interview studies addressed this variable; however, significant differences remained in 2 studies where the diabetic and control subjects were merely in the same age range (6,20; Table 4). Age was addressed in all 5 depression symptom scale studies. Sex. Adjustment for this potential bias was made in all 4 interview studies and all 5 corroborating depression symptom scale studies. Sdcioeconomic status. Socioeconomic status was not measured in 2 interview studies (6,24), did not differ significantly between diabetic and control samples in 1 interview study (5) , and did differ significantly between diabetic and control samples in 1 interview study (20 (7, 25) , and did differ significantly between diabetic and control samples (9; Table 4 ). Obesity. Depression in diabetes may not necessarily be a function of the diabetic condition, but of the obesity that frequently accompanies diabetes. This potential confounding factor, particularly in NIDDM, was wholly ignored in the 4 DIABETES CARE, VOLUME 16, NUMBER 8, AUGUST 1993 interview studies. Only 1 depression symptom scale study adjusted for this variable (25) . Assortative mating. This bias would be applicable only to studies that used spouses in the diabetic and control groups. The interview studies did not use spouses. The 2 depression symptom scale studies that did so did not address this potential bias (8, 25) . Concomitant medical illness. Two interview studies minimized the bias of concomitant medical illness in the diabetic (6) and control sample (24) through exclusionary criteria. Similar minimization occurred in the diabetic sample in 1 depression symptom scale study (7) . The interview study by Weyerer et al. (5) was the only other study to address this issue. The potential magnitude of this bias was serious in that many diseases besides diabetes were found to be associated with depression.
The higher prevalence of lifetime major depressive disorder in the diabetic sample in the interview study by Wells et al. (24) could partly reflect a concomitant medical illness artifact. Arthritis (14.3%), heart disease (18.6%), hypertension (16.4%), chronic lung disease (17.9%), and diabetes (14.4%) were all found to have a significantly increased prevalence of lifetime depression relative to healthy control subjects (6.9%), and the five medical disease categories overlapped. Concomitant medical illness could also explain the increased prevalence of clinically significant depression symptomatology in diabetic individuals (21.8%) relative to nondiabetic individuals (16.0%) found by Murrell et al. (8) . Kidney disease (31.3%), heart trouble (30.6%), lung trouble (36.4%), hardening of the arteries (33.8%), and stroke (57.0%) were also found to be associated with an increased risk of such symptomatology. The diabetic subjects could have had any accompanying illness, and the control subjects could have had any combination of illness except diabetes. The increased prevalence of clinically significant depression symptomatology in the diabetic sample thus could not be ascribed conclusively to diabetes.
The interview study by Weyerer et al. (5) was the only controlled investigation that addressed the potential bias of concomitant medical illness in both the diabetic and control sample. The diabetes and other somatic illness groups were mutually exclusive, and the healthy control subjects were free of somatic disease. Severity. The relationship of diabetes severity to the prevalence of major depressive disorder was examined in 3 of 4 interview studies. Weyerer et al. (5) found that the increased prevalence of depression in diabetic subjects compared with subjects having another somatic illness was not a function of severity of disease. The severity ratings, however, appeared to be largely subjective estimates on the part of the psychiatrist interviewer. Bias could have affected the ratings, as the evaluations were not blind. Robinson et al. (20) found that diabetic individuals who were currently depressed did not have a significantly greater amount of macrovascular or any type of complications than diabetic individuals who were not currently depressed. Popkin et al. (6) found no relationship between depression and either duration of diabetes or diabetic complications. Patients in this study, however, had had IDDM for a median duration of 20 yr and were being reviewed as pancreatic transplantation candidates. The lack of association of depression with diabetic complications could be indicative of the homogeneity of severity of diabetes. The relationship of depression and diabetes severity remains largely unknown.
The relationship of diabetes severity with clinically significant depression symptomatology was not measured in any depression symptom scale study (7) (8) (9) 25 
Physician corroboration of diabetes.
A major methodological problem of 1 community interview study was the lack of physician corroboration of self-reported diabetes (24) . The magnitude of this potential bias was seen in that 154 individuals reported a history of diabetes sometime during their lifetime, but only 114 reported currently having the condition. Inaccurate or transient definitions of diabetes such as impaired glucose tolerance, borderline diabetes, and gestational diabetes could have been considered valid by subjects. Verification is essential to ensure the use of those with a permanent diabetic condition. Physician verification of self-reported diabetes (8, 26) and other somatic illnesses that were used for comparison purposes (8) also did not occur in community depression symptom scale studies.
Physician corroboration of selfreported diabetes and other somatic illnesses was obtained for 80% of the subjects in 1 community interview study (5) . Time frame of depression. The time frame of depression assessment could hinder the comparability of studies. Only 2 of the interview studies measured lifetime depression (6, 24) . Although current depression was measured in all 4 interview studies, it was defined in numerous ways, which included within the last 7 days (5), within the last 1 mo (20) , and within the last 6 mo (6,24). The depression symptom scale studies measured current depression as defined as mood at the moment of evaluation (7) and within the last 7 days (8,9,25 R.B. Montague, W.W. Eaton, D.B. Larson, M.C. Mengel, L.S. Mengel, R. Campbell, unpublished observations). This variability in assessment period could explain, in part, differences in the findings. Participation rate. Participants may differ significantly from nonparticipants in the prevalence of depression. The likelihood of obtaining valid conclusions thus increases with higher participation rates. All 4 interview studies reported participation rates. An 85% participation rate of the eligible diabetic sample was obtained by Robinson et al. (20) , whereas Popkin et al. (6) reported that 100% of candi-dates being reviewed for pancreatic transplantation received psychiatric interviewing. The participation rates in the 2 community interview studies were 68 (24) and 93% (5) . Several of the depression symptom scale studies did not report participation rates (7, 9, 25) . Other methodological issues. Two other methodological problems were present in several of the controlled studies. One potential bias was that diabetic patients ascertained from a single hospital or clinic could hinder generalizability of the findings. Treatment samples may be measuring the severity of disease and/or accessibility of health care, and may not reflect the entire spectrum of diabetes. A second problem was that small sample sizes precluded the finding of significant differences between the diabetic and control groups.
Ascertainment bias-Ascertainment bias may be partly responsible for the increased prevalence of depression in the diabetic treatment sample in the interview study by Popkin et al. (6) ; however, it is unlikely to account for the entirety of the findings. The strength of the association was marked, as the rates of depression among individuals with diabetes were 3 -4 times the rates in the comparison groups (6) . Corroboration was also provided by 2 depression symptom scale studies that used treatment samples of individuals with other diseases as control subjects (7, 9) . This type of study served the dual purpose of ascertaining the diabetic and comparison groups in the same manner and documenting that diabetes could be differentiated from other diseases in the risk of clinically significant depression symptomatology. The increased prevalence of depression found in individuals with diabetes from the controlled community interview studies, however, provide perhaps the most convincing evidence against a potential ascertainment bias related to increased health-care use by depressed diabetic individuals (5, 24) .
The equivalent rates of current depression in the diabetic and control groups found in the interview study by Robinson et al. (20) appear on the surface to indicate that depression is no more common in people with diabetes than in the general population once a control for ascertainment bias is imposed. Both the diabetic and nondiabetic groups were derived from assigned primary care physician lists independent of health-care-seeking activity. The strict diagnostic criteria of the PSE, however, could account for the similarity in rates in that only severe depression cases were likely detected.
Sample size-A methodological problem of the two treatment interview studies was small sample size. Findings were based on 8 depressed diabetic pancreatic recipients versus 1 depressed nondiabetic donor (6), and 11 depressed diabetic individuals contained on primary care physician lists versus 11 depressed nondiabetic individuals included on the same lists (20) . The presence or magnitude of significant differences might not have been found because the sample sizes did not provide the necessary power to detect them. Findings were also based on only 7 depressed diabetic spouses versus 4 depressed nondiabetic spouses in 1 depression symptom scale study (25) .
CONCLUSIONS -The past decade of research has seen a proliferation of studies investigating the comorbidity of mental and physical illness. Depression may have special clinical relevancy in diabetes through its purported association with poor glycemic control and decreased adherence to treatment modalities. A comprehensive literature review was undertaken to ascertain the prevalence of depression in adult diabetic populations and to evaluate study methods and findings from an epidemiological perspective. Two issues were addressed: 1) whether diabetes was associated with an increased prevalence of depression; and 2) whether diabetes could be differentiated from other somatic illnesses in the risk of depression. Nine controlled studies and 11 uncontrolled studies were examined.
A significantly increased prevalence of depression or a significantly increased mean level on a depression symptom scale was found for diabetic samples compared with control samples in 8 of 9 controlled studies. The range of the prevalence of current depression obtained from structured diagnostic interviews in diabetic samples was 8.5-27.3% (X = 14.0%) in controlled studies and 11.0-19.9% (X = 15.4%) in uncontrolled studies. These estimates are several times the 3-4% prevalence of depression in the general adult population of the U.S. Investigations using depression symptom scales corroborated these findings, as the range of clinically significant depression symptomatology in diabetic samples was 21.8-60.0% (X = 32.4%) in controlled studies and 10.0-28.0% (X = 19.6%) in uncontrolled studies. Our review of the literature suggests that diabetic individuals are at greater risk for depression than the general adult population.
Whether depression is more common in diabetes than in other chronic diseases was far less supported by the literature. One controlled interview study found a significantly increased prevalence of lifetime depression for diabetes as well as for several other chronic diseases (24) . Corroboration was provided through 1 controlled depression symptom scale study, which found that many somatic illnesses including diabetes were significantly associated with an increased prevalence of clinically significant depression symptomatology (8) .
Neither of these studies, however, controlled for socioeconomic status, obesity, concomitant medical illness, or severity of medical illness, or verified a diagnosis of self-reported diabetes. The latter could have been a potentially serious bias in the interview study, as 40 (26%) of 154 subjects may not have even had a or permanent diabetic condition (24) . This study further had a relatively low response rate (68%).
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The controlled community interview study by Weyerer et al. (5) was the strongest investigation from a bias adjustment and methodologic standpoint. This study found an increased, although nonsignificant, prevalence of current depression in diabetic individuals (27.3%) compared with individuals with another somatic illness (20.3%). Two corroborating depression symptom scale studies did find a significantly increased prevalence of clinically significant depression symptomatology in diabetic samples than in other medically ill samples (7, 9 ). An increased prevalence of depression in diabetes relative to other somatic illnesses at this point remains unproven until further research is performed.
The prevalence of current depression in the diabetic sample in the study by Weyerer et al. (5) was much higher than in the 3 other controlled interview studies. This discrepancy warrants further elaboration. The diabetic group, other somatic illness group, and healthy control group had prevalences of mild psychiatric disorders of 23.6, 24.7, and 10.7%, respectively, and of moderate to severe psychiatric disorders of 19.5, 26.0, and 15.5%, respectively (P < 0.05) (5) . One difference between diabetic individuals and healthy control subjects thus appeared to be more mild psychiatric disorders in the diabetes group. The prevalence of any psychiatric disorder of any severity other than depression was virtually identical between diabetic individuals (15.8%) and healthy control subjects (15.6%), but was twice as high in those with other somatic diseases (30.4%; P < 0.05). These findings indicate that diabetes may have a special propensity for depression and not for other psychiatric illnesses, and that people with diabetes may be especially at risk for mild cases of depression.
Spurious depression prevalence estimates could have resulted if the diabetic and control samples differed significantly on variables known to be associated with an increased risk of depression. All 4 interview studies adequately controlled for sex, although only 2 controlled for age. Socioeconomic status, obesity, concomitant medical illness, and severity were also not adjusted for through either sample selection or analyses in several of the interview studies. A lack of physician verification of diabetes, different assessment periods of depression, small sample sizes, and low participation rates may have also applied. The variability in depression assessment methods further hindered comparability of studies. These potential biases and methodological problems were even more pronounced in the corroborating depression symptom scale studies, although all 5 studies did adequately control for age and sex.
Despite the potential biases and methodological difficulties, the increased prevalence of depression in diabetes likely signifies a true association. The relationship was found for 3 of 4 interview studies and all 5 corroborating depression symptom scale studies, despite the variety of diabetic and control samples used and the different depression assessment methods employed. Although confounding could have been present in either the diabetic or control samples, the association nevertheless favored the diabetic samples in 8 of 9 controlled studies.
Diabetes and depression may share various somatic symptoms such as fatigue and sexual dysfunction. An increased prevalence of clinically significant depression symptomatology in diabetic samples thus could be partly attributed to a diabetes artifact. It is unlikely, however, that such overlapping somatic symptoms could raise the score on depression symptomatology scales into the clinically significant range. Depressed and nondepressed diabetic individuals have been found to be easily distinguishable, particularly through cognitive symptoms of depression (51). Other studies have shown that the reporting of shared somatic symptoms is more attributable to depression than to conventional markers of diabetes (52, 53). These findings support that although depression symptomatology scales are not diagnostic for major depression, they may still be useful to corroborate an increased prevalence of depression in diabetes.
The 2 controlled community interview investigations provide an especially persuasive argument for an increased prevalence of depression in diabetes. Ascertainment bias is minimized in community studies in that diabetic individuals are identified apart from health-care-seeking activity. The generalizability of findings is also strong in such studies, as a broad range of diabetes is represented. The entire spectrum of diabetes, however, can never be fully obtained from either a treatment or community study in that > 50% of all cases of diabetes in the U.S. are asymptomatic (54). Although community samples are likely more representative of the range of diabetes than treatment samples, the relationship of depression with diabetes can never be fully ascertained.
Significant findings are usually far more likely to be submitted for publication and to appear in publication than studies that fail to document such associations (55). Publication bias was minimized in this review through the use of all known studies, published or unpublished, on the prevalence of depression in adult diabetic populations. The In summary, an increased prevalence of depression in diabetes relative to the general adult population is highly suggested by the literature. Future studies are needed that will address the potential biases and methodological issues outlined above to identify the absolute strength of this association. An increased prevalence of depression in diabetes relative to other somatic illnesses remains unproven. Studies are also needed that investigate depression according to sex, emphasize lifetime depression, and further discriminate between nonspecific effects of chronic illness and depression specifically related to diabetes. Family studies would be extremely useful for studying genetic-environmental interactions of the two diseases.
Prevalence findings can never prove causality, but may corroborate certain purported etiological theories as well as generate hypotheses for further testing. Evidence does exist for the biological plausibility of an association of depression with diabetes. Both have been associated with dysregulation of hypothalamic-pituitary-adrenocortical activity, resulting in abnormal cortisol production (56). Diabetic individuals without depression also show the same abnormal response to dexamethasone suppression tests as do nondiabetic individuals who are depressed (57). Functional deficiencies in norepinephrine and serotonin are believed to be associated with depression (58); these neurotransmitters have also been implicated in animal models for diabetes (59). Although speculative, such physiological associations could corroborate the propensity of diabetic individuals for depression but not for other psychiatric disorders found by Weyerer et al. (5) and Wells et al. (24, 60) .
